TABLE 1.

Characteristics of the SNP summary statistics for ADAMTS13 and outcomes.

Trait	First author	Consortium	Sample size	Number of variants	Population
ADAMTS13 level	Ma	NA	3244	153	European (majority)
ADAMTS13 activity (in citrated plasma)	de Vries	NA	5448	4	European
Coronary heart disease	Nikpay	CARDIoGRAMplusC4D	171,875	9,289,492	European (majority)
Myocardial infarction	Nikpay	CARDIoGRAMplusC4D	171,875	9,289,492	European (majority)
Atrial fibrillation	Neale	UK Biobank	337,199	10,894,596	European
Heart failure	Neale	UK Biobank	361,194	9,806,537	European
Ischemic stroke	Neale	UK Biobank	361,194	12,404,026	European
Venous thromboembolism	Neale	UK Biobank	361,194	11,901,177	European

SNP, single-nucleotide polymorphism.